Two independent epigenome-wide association studies of Alzheimer's disease cohorts have identified overlapping methylation signals in four loci, ANK1, RPL13, RHBDF2 and CDH23, not previously associated with Alzheimer's disease. These studies also suggest that epigenetic changes contribute more to Alzheimer's disease than expected.
This is a preview of subscription content, log in via an institution to check access.
References
Brookmeyer, R., Johnson, E., Ziegler-Graham, K. & Arrighi, H.M. Alzheimers Dement. 3, 186–191 (2007).
Lambert, J.C. et al. Nat. Genet. 45, 1452–1458 (2013).
Ertekin-Taner, N. Genetics of Alzheimer disease in the pre- and post-GWAS era. Alzheimers Res. Ther. 2, 3 (2010).
Lunnon, K. et al. Nat. Neurosci. 17, 1164–1170 (2014).
De Jager, P.L. et al. Nat. Neurosci. 17, 1156–1163 (2014).
Mazzio, E.A. & Soliman, K.F. Epigenetics 7, 119–130 (2012).
Mill, J. & Heijmans, B.T. Nat. Rev. Genet. 14, 585–594 (2013).
Bennett, D.A. et al. Transl. Res. published online, doi:10.1016/j.trsl.2014.05.006 (19 May 2014).
Hernandez, D.G. et al. Hum. Mol. Genet. 20, 1164–1172 (2011).
Davies, M.N. et al. Genome Biol. 13, R43 (2012).
Coppieters, N. et al. Neurobiol. Aging 35, 1334–1344 (2014).
Hollingworth, P. et al. Nat. Genet. 43, 429–435 (2011).
Seshadri, S. et al. JAMA 303, 1832–1840 (2010).
Kong, W. et al. Mol. Neurodegener. 4, 5 (2009).
Jayaraman, A. & Pike, C.J. Curr. Diab. Rep. 14, 476 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Lord, J., Cruchaga, C. The epigenetic landscape of Alzheimer's disease. Nat Neurosci 17, 1138–1140 (2014). https://doi.org/10.1038/nn.3792
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn.3792
- Springer Nature America, Inc.
This article is cited by
-
Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects
Alzheimer's Research & Therapy (2023)
-
Identification of candidate DNA methylation biomarkers related to Alzheimer’s disease risk by integrating genome and blood methylome data
Translational Psychiatry (2023)
-
METTL3-dependent RNA m6A dysregulation contributes to neurodegeneration in Alzheimer’s disease through aberrant cell cycle events
Molecular Neurodegeneration (2021)
-
Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer’s disease and related tauopathies
Acta Neuropathologica (2021)
-
DNA methylation-based measures of accelerated biological ageing and the risk of dementia in the oldest-old: a study of the Lothian Birth Cohort 1921
BMC Psychiatry (2020)